MSME (Udyam registered) Ministry of MSME
- Category
- Micro (2024-25)
- Udyam number
- UDYAM-DL-03-0009836
Anise Pharmaceuticals Private Limited
Anise Pharmaceuticals Private Limited - trading in Delhi, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹10.63 Lakh
▼ 13% YoY
Net profit · FY 2025
₹10,046
Net margin 0.9%
EBITDA · FY 2025
₹75,561
EBITDA margin 7.1%
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Open charges
₹5 Lakh
Secured borrowings
Company age
14 yrs
Est. 2012
Directors on board
2
As per MCA filings
About Anise Pharmaceuticals Private Limited
Data last updated:
Anise Pharmaceuticals Private Limited is a private limited company based in Delhi, India. It operates in the wholesale distribution segment of the trading and commerce sector. It was incorporated on 09 February 2012 and has been in existence for over 14 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U24100DL2012PTC231219. Its GSTIN is 10AAKCA3687Q1Z7 (Bihar).
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Pawan Kumar and Sandhya Devi.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at C – 112 Antriksh Apartments Sector – 14 Ext. Rohini, Delhi, India – 110085.
As per the financials filed for FY 2025, the company reported a revenue of ₹10.63 Lakh, a decline of 13% compared to the previous year. For the same year it recorded a net profit of ₹10,046 (net margin 0.9%) and EBITDA of ₹75,561 (EBITDA margin 7.1%). Revenue has declined at a compounded annual rate (CAGR) of 22% over three years and 19% over five years.
As per MCA filings, the company has open charges of ₹5 Lakh on record.
Anise Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0009836). The current compliance status is marked as compliant by the Registrar of Companies.
Company details
CIN U24100DL2012PTC231219
Registration Number 231219
Incorporation Date 09 February 2012
ROC Delhi
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Compliance Status Active Compliant
MSME Classification Micro
Udyam Registration UDYAM-DL-03-0009836
Key People
Pawan Kumar Director Sandhya Devi Director Recognitions & Rankings of Anise Pharmaceuticals
Contact details
Anise Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address is in the company report.
- Email
- Registered AddressC – 112 Antriksh Apartments Sector – 14 Ext. Rohini, Delhi, India – 110085
- IndustryTrading, Other Wholesale, Wholesale
To see the full contact details of Anise Pharmaceuticals Private Limited, buy the company report.
Comprehensive company report
Anise Pharmaceuticals Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business activity
The main business activity of Anise Pharmaceuticals is trade. In detail, this covers retail trading.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| G | Trade | G2 | Retail Trading |
To see the full business activity and turnover split of Anise Pharmaceuticals Private Limited, buy the company report.
Financials of Anise Pharmaceuticals Private Limited
FY 2025 filings availableAnise Pharmaceuticals Private Limited reported revenue of ₹10.63 Lakh (down 13% YoY) for FY 2025.
Revenue · FY 2025
₹10.63 Lakh ▼ 13%
Net profit · FY 2025
₹10,046 margin 0.9%
EBITDA · FY 2025
₹75,561 margin 7.1%
Compounded Annual Growth Rate (CAGR)
Revenue CAGR growth
1 year
▼ 13%
3 years · compounded
▼ 22%
5 years · compounded
▼ 19%
EBITDA CAGR growth
1 year
▲ 6%
5 years · compounded
▼ 3%
Revenue has declined at a compounded annual rate (CAGR) of 19% over five years, including a 13% fall in the latest year. EBITDA rose 6% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹75,561 | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹10,046 | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 7.1% | ||||
| Net Profit Margin | 0.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Anise Pharmaceuticals Private Limited, buy the company report.
Board of directors of Anise Pharmaceuticals Private Limited
Anise Pharmaceuticals has 2 current directors and 1 former director. Current directors are listed first, with their designation and appointment date.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Pawan Kumar | Director | 09 Feb 2012 | 14 Years 8 Months | Current |
| Sandhya Devi | Director | 09 Feb 2012 | 14 Years 8 Months | Current |
Peer comparison
Anise Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Zenopsis Pharmaceuticals Private Limited | ₹10.64 Lakh (FY 2020) | 63.0% | Lucknow, Uttar Pradesh, India | |||
| Anise Pharmaceuticals Private Limitedthis company | ₹10.63 Lakh (FY 2025) | ₹10,046 | 0.9% | -13.0% | Delhi, India | |
| Aglaea Pharmaceuticals Private Limited | ₹10.63 Lakh (FY 2021) | 450.0% | New Delhi, Delhi, India | |||
| Yestomo Pharmaceuticals Private Limited | ₹10.62 Lakh (FY 2024) | 33.0% | Hyderabad, Telangana, India |
To see the full peer comparison of Anise Pharmaceuticals Private Limited, buy the company report.
Auditor
Anise Pharmaceuticals Private Limited is audited by RAVINDER JAIN AND CO for the financial year 2017.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| RAVINDER JAIN AND CO | FY 2017 | 024725N |
Shareholding
The shareholding of Anise Pharmaceuticals Private Limited is on record for 2 financial years, the latest being FY 2017, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2017 | FY 2016 |
|---|---|---|
| Promoters | ||
| Domestic institutional investors (DII) | ||
| Foreign institutional investors (FII) | ||
| Public | ||
| Others |
To see the full shareholding pattern of Anise Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
Open charges
₹5 Lakh
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 01 Mar 2019 | 100268231 | Syndicate Bank | ₹5 Lakh | Open |
Total charge records: 1 View all charges
Legal cases
No court or tribunal cases involving Anise Pharmaceuticals Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Anise Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Anise Pharmaceuticals has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 10AAKCA3687Q1Z7 | Bihar | Active | 01 Jul 2017 |
To see the full GST registrations and return filing status of Anise Pharmaceuticals Private Limited, buy the company report.
Recent activity
Anise Pharmaceuticals Private Limited has 3 board changes on record since 2012: 2 appointments and 1 cessation. The latest: Biswa Mohan Kumar Srivastava ceased to be Director on 31 Mar 2021.
AGM
Anise Pharmaceuticals Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Anise Pharmaceuticals Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Delhi.
Ceased
Biswa Mohan Kumar Srivastava ceased to be Director.
Charges
A charge with Syndicate Bank amounted to Rs. 5.00 Lakh with Charge ID 100268231 was registered on 01 Mar 2019.
Appointed
Pawan Kumar was appointed as Director.
Appointed
Sandhya Devi was appointed as Director.
Incorporation
09 Feb 2012
Anise Pharmaceuticals Private Limited was registered on 09 Feb 2012 with Roc Delhi & aged 14 years 8 months as per MCA records.
Frequently asked questions
Anise Pharmaceuticals is an active private limited company based in Delhi, India. The company works in other wholesale, within the trading industry. It was incorporated on 09 February 2012 (14+ years old) and is registered under CIN U24100DL2012PTC231219.
Anise Pharmaceuticals has 2 current directors:
- Pawan Kumar - Director
- Sandhya Devi - Director
The latest financial statements of Anise Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from 2015 are in the company report.
The GSTIN of Anise Pharmaceuticals is 10AAKCA3687Q1Z7, registered in Bihar.
The CIN (Corporate Identification Number) of Anise Pharmaceuticals is U24100DL2012PTC231219. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Anise Pharmaceuticals was incorporated on 09 February 2012, making it 14+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Anise Pharmaceuticals by revenue are Zenopsis Pharmaceuticals Private Limited, Aglaea Pharmaceuticals Private Limited, Yestomo Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (retail trading).
Biswa Mohan Kumar Srivastava ceased to be Director on 31 Mar 2021. Pawan Kumar was appointed as Director on 09 Feb 2012. Sandhya Devi was appointed as Director on 09 Feb 2012.
Yes, Anise Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0009836).
The registered office of Anise Pharmaceuticals is at C – 112 Antriksh Apartments Sector – 14 Ext. Rohini, Delhi, India – 110085.
Anise Pharmaceuticals operates in the trading industry, in the other wholesale segment.